126 related articles for article (PubMed ID: 38795426)
1. Analytical Quality by Design as applied to the development of a SEC-HPLC platform procedure for the determination of monoclonal antibody purity without mobile phase additives.
Cernosek T; Dalphin M; Jain N; Richter N; Beard S; Wang J; Osborne J; Stone T; Mellal M; Behrens S; Wunderli P
J Pharm Biomed Anal; 2024 Aug; 246():116220. PubMed ID: 38795426
[TBL] [Abstract][Full Text] [Related]
2. A case study application of AQbD to the re-development and validation of an affinity chromatography analytical procedure for mAb titer quantitation.
Cernosek T; Dalphin M; Jain N; Lor J; Richter N; Mellal M; Behrens S; Wunderli P
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jun; 1242():124205. PubMed ID: 38880058
[TBL] [Abstract][Full Text] [Related]
3. Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments.
Cernosek T; Jain N; Dalphin M; Behrens S; Wunderli P
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Mar; 1235():124037. PubMed ID: 38335765
[TBL] [Abstract][Full Text] [Related]
4. Using Analytical Quality by Design to improve analytical method development in vaccines quality control: Application to an optimized quantitative high-performance anion-exchange chromatographic method.
Moineau I; Chambon V; Perret C; Gouit L; Zamora I; Macumi M; Fertier-Prizzon S; Pitiot O
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123946. PubMed ID: 38217970
[TBL] [Abstract][Full Text] [Related]
5. Development of a generic reversed-phase liquid chromatography method for protein quantification using analytical quality-by-design principles.
Kopp J; Zauner FB; Pell A; Hausjell J; Humer D; Ebner J; Herwig C; Spadiut O; Slouka C; Pell R
J Pharm Biomed Anal; 2020 Sep; 188():113412. PubMed ID: 32590301
[TBL] [Abstract][Full Text] [Related]
6. Analytical Lifecycle Management (ALM) and Analytical Quality by Design (AQbD) for analytical procedure development of related substances in tenofovir alafenamide fumarate tablets.
Teng J; Zhu C; Lyu J; Pan L; Zhang M; Zhang F; Wu H
J Pharm Biomed Anal; 2022 Jan; 207():114417. PubMed ID: 34678556
[TBL] [Abstract][Full Text] [Related]
7. Combined Protein A and size exclusion high performance liquid chromatography for the single-step measurement of mAb, aggregates and host cell proteins.
Gjoka X; Schofield M; Cvetkovic A; Gantier R
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Dec; 972():48-52. PubMed ID: 25310707
[TBL] [Abstract][Full Text] [Related]
8. Column-free optical deconvolution of intrinsic fluorescence for a monoclonal antibody and its product-related impurities.
Uçan D; Hales JE; Aoudjane S; Todd N; Dalby PA
J Chromatogr A; 2023 Nov; 1711():464463. PubMed ID: 37866332
[TBL] [Abstract][Full Text] [Related]
9. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
[TBL] [Abstract][Full Text] [Related]
10. Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry.
Liu H; Gaza-Bulseco G; Chumsae C
J Am Soc Mass Spectrom; 2009 Dec; 20(12):2258-64. PubMed ID: 19786356
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of a LC-MS/MS compatible method for quantification of losartan, hydrochlorothiazide and their impurities using AQbD approach and measurement uncertainty evaluation.
Rocha AL; Lourenço FR
Talanta; 2023 Jul; 259():124481. PubMed ID: 36989967
[TBL] [Abstract][Full Text] [Related]
12. DoE-Based Analytical-FMCEA for Enhanced AQbD Approach to MEER-RP-HPLC Method for Synchronous Estimation of 15 Anti-Hypertensive Pharmaceutical Dosage Forms.
Prajapati PB; Patel AS; Shah SA
J AOAC Int; 2022 Feb; 105(1):34-45. PubMed ID: 34293098
[TBL] [Abstract][Full Text] [Related]
13. Determination of interactions between antibody biotherapeutics and copper by size exclusion chromatography (SEC) coupled with inductively coupled plasma mass spectrometry (ICP/MS).
Luo Y; Ronk M; Joubert MK; Semin D; Nashed-Samuel Y
Anal Chim Acta; 2019 Nov; 1079():252-259. PubMed ID: 31387718
[TBL] [Abstract][Full Text] [Related]
14. A sub-two minutes method for monoclonal antibody-aggregate quantification using parallel interlaced size exclusion high performance liquid chromatography.
Diederich P; Hansen SK; Oelmeier SA; Stolzenberger B; Hubbuch J
J Chromatogr A; 2011 Dec; 1218(50):9010-8. PubMed ID: 22078232
[TBL] [Abstract][Full Text] [Related]
15. DoE-assisted development and validation of a stability-indicating HPLC-DAD method for simultaneous determination of five cannabinoids in Cannabis sativa L. based on analytical quality by design (AQbD) concept.
de Souza MR; Koetz M; Limberger RP; Henriques AT
Phytochem Anal; 2022 Oct; 33(7):999-1017. PubMed ID: 35733081
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
17. Analytical QbD: development of a native gel electrophoresis method for measurement of monoclonal antibody aggregates.
Pathak M; Dutta D; Rathore A
Electrophoresis; 2014 Aug; 35(15):2163-71. PubMed ID: 24643784
[TBL] [Abstract][Full Text] [Related]
18. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy.
Radić I; Runje M; Babić S
J Pharm Biomed Anal; 2021 Jul; 201():114091. PubMed ID: 33964725
[TBL] [Abstract][Full Text] [Related]
19. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.
Xu CF; Zang L; Weiskopf A
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():230-8. PubMed ID: 24835510
[TBL] [Abstract][Full Text] [Related]
20. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
